Abstract
The implementation of hepatitis C (HCV) direct-acting antiviral drugs is prioritized in several populations in which its application provides the most immediate and impactful benefit. In this scenario, a precise knowledge of the situation of human immunodeficiency virus (HIV)/HCV chronic co-infection is required to adequately address this disease. This cross-sectional study was performed in 21 hospitals in Andalusia (Spain). The study population consisted of HIV-infected patients with an active HCV chronic infection who were not receiving HCV treatment at the time of inclusion. A total of 13,506 HIV-infected patients were included in the study. Of them, 2561 (18.9 %) presented chronic HCV infection. The majority of the patients included were on highly active antiretroviral therapy (HAART; 96.2 %), showed plasma levels with an undetectable HIV viral load (92.5 %), and had a good immunological status (median CD4+ cell count of 486 cells/mL). The HCV genotype distribution was as follows: 58.1 % were genotype 1, 1.1 % were genotype 2, 16.1 % were genotype 3, and 22.1 % were genotype 4 (2.6 % were missing data). In total, 24.8 % of the patients showed liver fibrosis stage F0-F1, 27.9 % showed stage F2, 16.7 % showed stage F3, and 21...Continue Reading
References
Dec 4, 2002·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J MacíasJ A Pineda
Dec 6, 2005·AIDS·Nicolás MerchanteUNKNOWN Grupo Andaluz para el Estudio de las Enfermedades Infecciosas
Feb 1, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Brian R Edlin, Michael R Carden
Jul 31, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Juan A PinedaUNKNOWN Grupo para el Estudio de las Hepatitis Víricas de la Sociedad Andaluza de Enfermedades Infecciosas (SAEI)
Nov 21, 2007·Journal of Hepatology·Juan I EstebanJosep Quer
Jan 29, 2008·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Colette SmitMaria Prins
Sep 24, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Juan A PinedaUNKNOWN Grupo para el Estudio de las Hepatitis Víricas (HEPAVIR) de la Sociedad Andaluza de Enfermedades Infecciosas
Jun 20, 2012·Journal of Hepatology·Victoria HernandoUNKNOWN CoRIS
Jul 12, 2012·AIDS·Juan BerenguerUNKNOWN CoRIS (AIDS Research Network Cohort)
Nov 23, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Khayriyyah Mohd HanafiahSteven T Wiersma
Dec 27, 2012·JAMA : the Journal of the American Medical Association·Adriaan J van der MeerHarry L A Janssen
Feb 15, 2013·The Journal of Infectious Diseases·Arthur Y KimDaniel R Church
Feb 9, 2013·PloS One·Anna DaviesNathan Ford
Feb 23, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·José A MiraUNKNOWN Grupo Andaluz para el Estudio de las Hepatitis Víricas de la Sociedad Andaluza de Enfermedades Infecciosas
Aug 16, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Juan MacíasJuan A Pineda
Aug 22, 2013·BMC Infectious Diseases·Victoria HernandoUNKNOWN CoRIS cohort
Jan 18, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Monica A KonermanMark S Sulkowski
Mar 13, 2014·Alimentary Pharmacology & Therapeutics·J AmpueroK R Reddy
Apr 15, 2014·The New England Journal of Medicine·Nezam AfdhalUNKNOWN ION-1 Investigators
May 6, 2014·The New England Journal of Medicine·Peter FerenciUNKNOWN PEARL-IV Study
May 6, 2014·The New England Journal of Medicine·Stefan ZeuzemUNKNOWN VALENCE Investigators
May 14, 2014·Journal of Hepatology
Jul 20, 2014·JAMA : the Journal of the American Medical Association·Mark S SulkowskiUNKNOWN PHOTON-1 Investigators
Jul 30, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jane P MessinaEleanor Barnes
Aug 1, 2014·Lancet·Michael MannsUNKNOWN HALLMARK-DUAL Study Team
Aug 1, 2014·Lancet·Eric LawitzIra M Jacobson
Jan 17, 2015·Lancet·Anita KohliShyam Kottilil
Feb 24, 2015·JAMA : the Journal of the American Medical Association·Mark S SulkowskiThomas Podsadecki
Feb 24, 2015·JAMA : the Journal of the American Medical Association·Anu OsinusiShyam Kottilil
Citations
May 18, 2016·Open Forum Infectious Diseases·Juan BerenguerJuan González-García
Sep 17, 2016·BMC Infectious Diseases·Karin NeukamJuan A Pineda
Oct 28, 2016·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A Rivero-JuarezUNKNOWN HERACLES cohort study team of the Grupo de Estudio de Hepatitis Virales (HEPAVIR) of the Sociedad Andaluza de Enfermedades I
Aug 1, 2019·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·Lauren Mk MasonLara Tavoschi